Edwards Lifesciences (EW) EBITDA Margin Growth (3y) (2012 - 2026)
Edwards Lifesciences (EW) EBITDA Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.37 Bn | 193.76 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 127.75 Bn | 124.27 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 119.07 Bn | 109.85 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.64 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.38 Bn | 23.06 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 244.00 |
| 10 | Zimmer Biomet Holdings | 19.20 Bn | 18.79 Bn | 1.54 Bn | -265.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 887.00 |
| Mar 31, 2026 | -283.00 |
| Dec 31, 2025 | -3,636.00 |
| Sep 30, 2025 | -1,073.00 |
| Jun 30, 2025 | -661.00 |
| Mar 31, 2025 | -477.00 |
| Dec 31, 2024 | -560.00 |
| Sep 30, 2024 | -390.00 |
| Jun 30, 2024 | -1,263.00 |
| Mar 31, 2024 | -528.00 |
| Dec 31, 2023 | -210.00 |
| Sep 30, 2023 | -193.00 |
| Jun 30, 2023 | 3,895.00 |
| Mar 31, 2023 | 8.00 |
| Dec 31, 2022 | 1,952.00 |
| Sep 30, 2022 | 361.00 |
| Jun 30, 2022 | 883.00 |
| Mar 31, 2022 | 510.00 |
| Dec 31, 2021 | 2,870.00 |
| Sep 30, 2021 | 234.00 |